Rankings
▼
Calendar
CLDX Q1 2023 Earnings — Celldex Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CLDX
Celldex Therapeutics, Inc.
$2B
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$967,000
+455.7% YoY
Gross Profit
-$26M
-2671.3% margin
Operating Income
-$32M
-3357.9% margin
Net Income
-$29M
-3036.3% margin
EPS (Diluted)
$-0.62
QoQ Revenue Growth
-40.0%
Cash Flow
Operating Cash Flow
-$29M
Free Cash Flow
-$29M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$325M
Total Liabilities
$22M
Stockholders' Equity
$303M
Cash & Equivalents
$54M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$967,000
$174,000
+455.7%
Gross Profit
-$26M
-$17M
-53.0%
Operating Income
-$32M
-$23M
-39.6%
Net Income
-$29M
-$23M
-27.4%
Revenue Segments
Grant
$967,000
100%
← FY 2023
All Quarters
Q2 2023 →